iBio
CDMO SERVICES
THERAPEUTICS AND VACCINES
Overview
Fibrosis
IBIO-100
COVID-19
IBIO-200 VLP Vaccine
IBIO-201 Subunit Vaccine
Classical Swine Fever
IBIO-400
Virus-Like Particles
LicKM
INVESTORS
CAREERS
Contact Us
SEC Filings
Investors
Investors
Overview
Company Info
Profile
Management Team
News & Events
Press Releases
IR Calendar
Stock Info
Quote
Charts
Historical Data
SEC Filings
Governance
Board of Directors
Board Committees
Governance Documents
Resources
IR Contact
Email Alerts
Investor FAQ
Filing Type:
View All
10-12G
10-12G/A
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
CERTNYS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
FWP
NT 10-K
NT 10-Q
PRE 14A
REGDEX
RW
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC TO-C
SC TO-I
SC TO-I/A
UPLOAD
Year:
View All
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Date
Form
Description
PDF
XBRL
Pages
10/02/20
8-K
Current report filing
Documents
EX-99.1
5
09/28/20
NT 10-K
Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT
3
08/13/20
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
Documents
EX-1
9
08/13/20
8-K
Current report filing
3
08/11/20
4
Statement of changes in beneficial ownership of securities
1
08/11/20
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
Documents
EX-1
9
08/07/20
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
Documents
EX-1
8
08/06/20
4
Statement of changes in beneficial ownership of securities
1
08/06/20
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
Documents
EX-1
8
07/29/20
424B5
Prospectus filed pursuant to Rule 424(b)(5)
37
Previous
1
2
3
4
5
6
7
8
9
10
…53
Next
Email Alerts
Contacts
RSS News Feed